APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Launched by NATIONAL CANCER INSTITUTE (NCI) · Apr 23, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The APOLLO trial is studying the effects of a medication called olaparib in patients who have had surgery for pancreatic cancer and have specific genetic mutations (in genes called BRCA1, BRCA2, or PALB2). The goal is to see if taking olaparib after surgery and chemotherapy can help prevent the cancer from coming back. Olaparib works by blocking a protein that helps cancer cells repair their damaged DNA, which may make it harder for the cancer to survive.
To participate in this trial, patients must be at least 18 years old, have successfully undergone surgery for pancreatic cancer, and have no signs of cancer recurrence. They should have also received a certain amount of chemotherapy before the study. Participants will be randomly assigned to receive either olaparib or a placebo (a non-active pill) after their surgery. Throughout the trial, patients will be monitored for their health and any side effects. This research is important because it could help improve treatment options for pancreatic cancer patients with these specific genetic mutations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • STEP 0 (PRE-REGISTRATION) INCLUSION CRITERIA
- • Patient must be \>= 18 years of age on day of consent
- • Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- • Patient must have a diagnosis of pancreatic cancer and have successfully undergone a curative intent surgical resection and must have no evidence of recurrent disease as determined by the investigator
- • NOTE: This includes patients with adenocarcinoma, acinar carcinoma, squamous cell carcinoma adenosquamous and variants thereof. Patients with neuroendocrine tumors are excluded from enrolling
- • Patient must (1) be planning to receive, (2) be receiving or (3) have received at least three combined months (i.e., 12 weeks) of perioperative (neoadjuvant, adjuvant or a combination of both) systemic, multi-agent chemotherapy. Patients may have had up to 6 months of perioperative systemic therapy as deemed appropriate by their primary treating medical team (patients can have received radiation or chemoradiation in addition to this 6 month course)
- • Patient must be no more than 12 weeks from their most recent treatment (this may be chemotherapy, radiotherapy or surgery)
- • Patient must have a known pathogenic or likely pathogenic germline or somatic mutation in BRCA1, BRCA2, or PALB2, as determined by a Clinical Laboratory Improvement Amendments (CLIA) certified or equivalently-accredited laboratory. Mutations must be considered pathogenic or likely pathogenic by a reference database such as ClinVar or OncoKb.org
- • STEP 1 (RANDOMIZATION) INCLUSION CRITERIA
- • Patient must have met the eligibility criteria outlined above
- • Patient must have undergone at least 3 combined months (i.e., 12 weeks) of perioperative (neoadjuvant, adjuvant or a combination of both) systemic, multi-agent chemotherapy. Patients may have had up to 6 months of perioperative systemic therapy as deemed appropriate by their primary treating medical team (patients can have received radiation or chemoradiation in addition to this 6 months course)
- • Central expert reviewer must have determined the patient eligible for randomization after review of local genetic testing reports
- • If mutation in BRCA1, BRCA2 or PALB2 was identified in tumor tissue and the patient has not previously undergone germline testing, the patient must agree to undergo germline testing
- • Patient must have no evidence of recurrent or metastatic pancreatic cancer at the time of randomization as documented by baseline scans obtained =\< 4 weeks prior to Step 1 randomization
- • Patient must not have previously had evidence of progressive pancreatic cancer while receiving platinum-based therapy
- • Patient must be \>= 21 days (three weeks) from their last treatment (including chemotherapy radiotherapy or surgery) but =\< 84 days (twelve weeks) from their last treatment at the time of Step 1 randomization. Patients who have received neoadjuvant and/or adjuvant radiotherapy are eligible
- • Patient must have recovered from any adverse events due to prior anti-cancer therapy (i.e., have no residual toxicities \> grade 1 with the exception of alopecia and/or neuropathy)
- • Patient must not be receiving any other investigational agents at the time of Step 1 randomization and while on protocol treatment
- • Patient must not have any history of allergic reactions attributed to compounds of similar chemical or biological composition to olaparib
- • Patient must not have any personal history of myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Patients with myelodysplastic syndrome/acute myeloid leukemia or with features suggestive of MDS/AML.
- • Patient must not have any uncontrolled gastrointestinal disorder that would, in the opinion of the investigator, interfere with the ingestion or absorption of olaparib
- • Patient must not be pregnant or breast-feeding due the potential harm to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All patients of childbearing potential must have a blood test or urine study within 14 days prior to Step 1 randomization to rule out pregnancy. A patient of childbearing potential is defined as anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
- • Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after the last dose of protocol treatment for female patients and for 3 months after the last dose of protocol treatment for male patients. Patients must also not donate sperm while on protocol treatment and for 3 months after the last dose of protocol treatment. Patients must also not breast-feed while on protocol treatment and for 1 month after the last dose of protocol treatment
- • Leukocytes \>= 3,000/mcL (obtained =\< 28 days prior to Step 1 randomization)
- • Absolute neutrophil count \>= 1,500/mcL (obtained =\< 28 days prior to Step 1 randomization)
- • Platelets \>= 100,000/mcL (obtained =\< 28 days prior to Step 1 randomization)
- • Hemoglobin \>= 9.0 g/dL with no blood transfusion in the past 28 days (obtained =\< 28 days prior to Step 1 randomization)
- • Total bilirubin =\< 1.5 institutional upper limit of normal (ULN) except in patients with Gilbert's syndrome. Patients with Gilbert's syndrome may enroll if direct bilirubin =\< 2.5 x ULN of the direct bilirubin (obtained =\< 28 days prior to Step 1 randomization)
- • Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase \[SGOT\])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase \[SGPT\]) =\< 2.5 institutional ULN (obtained =\< 28 days prior to Step 1 randomization)
- • Creatinine =\< 1.5 institutional ULN OR calculated Cockcroft Gault creatinine clearance \> 50 mL/min/1.73 m\^2 (obtained =\< 28 days prior to Step 1 randomization)
- • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial
- • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated
- • Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
- • Patient must not have resting electrocardiogram (ECG) indicating uncontrolled, potentially reversible cardiac conditions, as judged by the investigator (e.g. unstable ischemia, uncontrolled symptomatic arrhythmia, congestive heart failure, corrected QT \[QTc\] prolongation \> 500 ms, electrolyte disturbances, etc.) or have congenital long QT syndrome
- • Concomitant use of known potent CYP3A4/5 inhibitors such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, telithromycin, clarithromycin and nelfinavir is prohibited
- • Patients who are being actively treated for an ongoing concurrent malignancy are ineligible, with the exception of those receiving adjuvant hormone therapies and those receiving topical therapies for skin cancers
- • Patient must not have, in the opinion of the investigator, any other concurrent medical condition that would prevent the patient from complying with the study procedures
- • Patient must not be considered a poor medical risk due to a serious, uncontrolled medical disorder, non-malignant systemic disease or active, uncontrolled infection. Examples include, but are not limited to, uncontrolled ventricular arrhythmia, recent (within 3 months) myocardial infarction, uncontrolled major seizure disorder, unstable spinal cord compression, superior vena cava syndrome, extensive interstitial bilateral lung disease on high resolution computed tomography (HRCT) scan or any psychiatric disorder that prohibits obtaining informed consent
- • Patient must have the ability to understand and the willingness to sign a written informed consent document, or have legally authorized representative provide authorization to participate
- • Patient must not have had major surgery within 2 weeks prior to Step 1 randomization and patients must have recovered from any effects of any major surgery
About National Cancer Institute (Nci)
The National Cancer Institute (NCI) is a prominent component of the National Institutes of Health (NIH), dedicated to advancing cancer research and improving patient outcomes through innovative clinical trials. As a leading sponsor of cancer-related studies, NCI focuses on facilitating the development of new therapies, enhancing prevention strategies, and understanding the biology of cancer. The institute collaborates with academic institutions, healthcare providers, and industry partners to conduct rigorous clinical trials that aim to translate scientific discoveries into effective treatments. NCI’s commitment to fostering a robust research environment supports the mission to eliminate cancer as a major health problem.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lebanon, New Hampshire, United States
Buffalo, New York, United States
Philadelphia, Pennsylvania, United States
Denver, Colorado, United States
Flint, Michigan, United States
Sioux Falls, South Dakota, United States
Haifa, , Israel
Peoria, Illinois, United States
South Bend, Indiana, United States
Baton Rouge, Louisiana, United States
Anchorage, Alaska, United States
Oklahoma City, Oklahoma, United States
Des Moines, Iowa, United States
La Crosse, Wisconsin, United States
New York, New York, United States
Ann Arbor, Michigan, United States
Cincinnati, Ohio, United States
Las Vegas, Nevada, United States
Dallas, Texas, United States
Rochester, New York, United States
Las Vegas, Nevada, United States
Mount Vernon, Illinois, United States
Salina, Kansas, United States
Bryn Mawr, Pennsylvania, United States
Yakima, Washington, United States
Coon Rapids, Minnesota, United States
Renton, Washington, United States
Urbana, Illinois, United States
Carroll, Iowa, United States
Ann Arbor, Michigan, United States
Minneapolis, Minnesota, United States
Saint Paul, Minnesota, United States
Council Bluffs, Iowa, United States
Dayton, Ohio, United States
Effingham, Illinois, United States
Lawrence, Kansas, United States
Lee's Summit, Missouri, United States
Saint Joseph, Missouri, United States
Johnson Creek, Wisconsin, United States
Longmont, Colorado, United States
Springfield, Illinois, United States
Cincinnati, Ohio, United States
Portland, Oregon, United States
Roseville, California, United States
Springfield, Illinois, United States
Media, Pennsylvania, United States
Washington, District Of Columbia, United States
Troy, Michigan, United States
Honolulu, Hawaii, United States
Salt Lake City, Utah, United States
Modesto, California, United States
Orlando, Florida, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Indianapolis, Indiana, United States
New Orleans, Louisiana, United States
Southfield, Michigan, United States
Saint Louis, Missouri, United States
Kearney, Nebraska, United States
New York, New York, United States
Bismarck, North Dakota, United States
Fargo, North Dakota, United States
Philadelphia, Pennsylvania, United States
Wynnewood, Pennsylvania, United States
Mountain View, California, United States
Aurora, Illinois, United States
Camden, New Jersey, United States
Kettering, Ohio, United States
Auburn, Washington, United States
Centralia, Washington, United States
Federal Way, Washington, United States
Lakewood, Washington, United States
Puyallup, Washington, United States
Morgantown, West Virginia, United States
Cape Girardeau, Missouri, United States
Elmhurst, Illinois, United States
Coos Bay, Oregon, United States
Pueblo, Colorado, United States
Saint Louis Park, Minnesota, United States
Saint Louis, Missouri, United States
Omaha, Nebraska, United States
Portland, Oregon, United States
Memphis, Tennessee, United States
Omaha, Nebraska, United States
Omaha, Nebraska, United States
Miami, Florida, United States
Royal Oak, Michigan, United States
Albuquerque, New Mexico, United States
Sioux Falls, South Dakota, United States
Dallas, Texas, United States
Detroit, Michigan, United States
Rochester, Minnesota, United States
Saint Louis, Missouri, United States
Las Vegas, Nevada, United States
Mineola, New York, United States
Green Bay, Wisconsin, United States
Madison, Wisconsin, United States
Marshfield, Wisconsin, United States
Honolulu, Hawaii, United States
Portland, Oregon, United States
Reno, Nevada, United States
Decatur, Illinois, United States
Ottawa, Illinois, United States
Peoria, Illinois, United States
Missoula, Montana, United States
Galesburg, Illinois, United States
Clive, Iowa, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Warren, Michigan, United States
Lincoln, Nebraska, United States
Papillion, Nebraska, United States
Anchorage, Alaska, United States
Omaha, Nebraska, United States
Cape Girardeau, Missouri, United States
Peru, Illinois, United States
Des Moines, Iowa, United States
Adrian, Michigan, United States
Monroe, Michigan, United States
Pontiac, Michigan, United States
Toledo, Ohio, United States
Bremerton, Washington, United States
Paoli, Pennsylvania, United States
Burbank, California, United States
Atlanta, Georgia, United States
'Aiea, Hawaii, United States
Honolulu, Hawaii, United States
Honolulu, Hawaii, United States
Alton, Illinois, United States
Galesburg, Illinois, United States
Ames, Iowa, United States
Kansas City, Kansas, United States
Pittsburg, Kansas, United States
Topeka, Kansas, United States
Bemidji, Minnesota, United States
Joplin, Missouri, United States
Kansas City, Missouri, United States
Kansas City, Missouri, United States
Springfield, Missouri, United States
Springfield, Missouri, United States
Reno, Nevada, United States
Dayton, Ohio, United States
Franklin, Ohio, United States
Toledo, Ohio, United States
Troy, Ohio, United States
Sioux Falls, South Dakota, United States
Tacoma, Washington, United States
Vancouver, Washington, United States
Green Bay, Wisconsin, United States
Minocqua, Wisconsin, United States
Oconomowoc, Wisconsin, United States
Oconto Falls, Wisconsin, United States
Rice Lake, Wisconsin, United States
Waukesha, Wisconsin, United States
Weston, Wisconsin, United States
Berkeley, California, United States
San Francisco, California, United States
Colorado Springs, Colorado, United States
Lakewood, Colorado, United States
Naperville, Illinois, United States
Bellingham, Washington, United States
Seattle, Washington, United States
Seattle, Washington, United States
Livonia, Michigan, United States
Kennewick, Washington, United States
Sedro Woolley, Washington, United States
Clackamas, Oregon, United States
Newberg, Oregon, United States
Munster, Indiana, United States
Littleton, Colorado, United States
Albuquerque, New Mexico, United States
Boise, Idaho, United States
Duluth, Minnesota, United States
Las Vegas, Nevada, United States
Louisville, Kentucky, United States
Council Bluffs, Iowa, United States
Goldsboro, North Carolina, United States
Canton, Illinois, United States
Carthage, Illinois, United States
Eureka, Illinois, United States
Kewanee, Illinois, United States
Macomb, Illinois, United States
Peru, Illinois, United States
Princeton, Illinois, United States
Appleton, Wisconsin, United States
Parker, Colorado, United States
Joplin, Missouri, United States
Lake Success, New York, United States
Walla Walla, Washington, United States
Orange, California, United States
Grand Island, Nebraska, United States
Carmel, Indiana, United States
Fort Smith, Arkansas, United States
Santa Rosa, California, United States
Vacaville, California, United States
Bloomington, Illinois, United States
Pekin, Illinois, United States
Hays, Kansas, United States
Bolivar, Missouri, United States
Saint Louis, Missouri, United States
Bend, Oregon, United States
Janesville, Wisconsin, United States
Saint Johnsbury, Vermont, United States
Teaneck, New Jersey, United States
Santa Rosa, California, United States
Fairbanks, Alaska, United States
Hot Springs, Arkansas, United States
Arroyo Grande, California, United States
Olathe, Kansas, United States
Jefferson City, Missouri, United States
Omaha, Nebraska, United States
Oklahoma City, Oklahoma, United States
Aberdeen, South Dakota, United States
Bryan, Texas, United States
Longview, Washington, United States
Bridgeport, West Virginia, United States
Jonesboro, Arkansas, United States
Sunnyvale, California, United States
Atlanta, Georgia, United States
Fruitland, Idaho, United States
Meridian, Idaho, United States
Nampa, Idaho, United States
Twin Falls, Idaho, United States
West Des Moines, Iowa, United States
Overland Park, Kansas, United States
Farmington Hills, Michigan, United States
Kansas City, Missouri, United States
Lee's Summit, Missouri, United States
Rolla, Missouri, United States
Rolla, Missouri, United States
Fargo, North Dakota, United States
Oregon City, Oregon, United States
Bellevue, Washington, United States
Burien, Washington, United States
Edmonds, Washington, United States
Everett, Washington, United States
Issaquah, Washington, United States
Lacey, Washington, United States
Urbana, Illinois, United States
Springfield, Illinois, United States
Longmont, Colorado, United States
Las Vegas, Nevada, United States
Anchorage, Alaska, United States
Santa Cruz, California, United States
Clive, Iowa, United States
West Des Moines, Iowa, United States
Garden City, Kansas, United States
Great Bend, Kansas, United States
Brighton, Michigan, United States
Canton, Michigan, United States
Chelsea, Michigan, United States
Clarkston, Michigan, United States
Clarkston, Michigan, United States
East China Township, Michigan, United States
Flint, Michigan, United States
Flint, Michigan, United States
Grosse Pointe Woods, Michigan, United States
Grosse Pointe Woods, Michigan, United States
Macomb, Michigan, United States
Pontiac, Michigan, United States
Pontiac, Michigan, United States
Saginaw, Michigan, United States
Sterling Heights, Michigan, United States
Warren, Michigan, United States
West Branch, Michigan, United States
Ypsilanti, Michigan, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Voorhees, New Jersey, United States
Clinton, North Carolina, United States
Jacksonville, North Carolina, United States
Centerville, Ohio, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Colorado Springs, Colorado, United States
Durango, Colorado, United States
Durango, Colorado, United States
Creston, Iowa, United States
Bardstown, Kentucky, United States
Corbin, Kentucky, United States
Lexington, Kentucky, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Shepherdsville, Kentucky, United States
Commack, New York, United States
Cincinnati, Ohio, United States
Cincinnati, Ohio, United States
Aberdeen, Washington, United States
Enumclaw, Washington, United States
Seattle, Washington, United States
Shelton, Washington, United States
Tacoma, Washington, United States
Yelm, Washington, United States
Altamonte Springs, Florida, United States
Kissimmee, Florida, United States
Orlando, Florida, United States
Orlando, Florida, United States
Winter Park, Florida, United States
Carbondale, Illinois, United States
Carterville, Illinois, United States
Centralia, Illinois, United States
Danville, Illinois, United States
Decatur, Illinois, United States
Effingham, Illinois, United States
Mattoon, Illinois, United States
New Lenox, Illinois, United States
O'fallon, Illinois, United States
Yorkville, Illinois, United States
Louisville, Kentucky, United States
Brighton, Michigan, United States
Canton, Michigan, United States
Chelsea, Michigan, United States
Ypsilanti, Michigan, United States
Sainte Genevieve, Missouri, United States
Sullivan, Missouri, United States
Sunset Hills, Missouri, United States
Dayton, Ohio, United States
Clackamas, Oregon, United States
Seattle, Washington, United States
Spokane Valley, Washington, United States
Spokane, Washington, United States
Spokane, Washington, United States
Sturgeon Bay, Wisconsin, United States
Montvale, New Jersey, United States
Harrison, New York, United States
Uniondale, New York, United States
Middletown, New Jersey, United States
Ames, Iowa, United States
Boone, Iowa, United States
Fort Dodge, Iowa, United States
Jefferson, Iowa, United States
Marshalltown, Iowa, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Basking Ridge, New Jersey, United States
Baton Rouge, Louisiana, United States
Novi, Michigan, United States
Columbus, Mississippi, United States
Grenada, Mississippi, United States
New Albany, Mississippi, United States
Oxford, Mississippi, United States
Southhaven, Mississippi, United States
Carson City, Nevada, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Reno, Nevada, United States
Gig Harbor, Washington, United States
Eau Claire, Wisconsin, United States
London, Kentucky, United States
Farmington, Utah, United States
Mukwonago, Wisconsin, United States
Waukesha, Wisconsin, United States
Des Moines, Iowa, United States
Overland Park, Kansas, United States
Westwood, Kansas, United States
Orland Park, Illinois, United States
Fairway, Kansas, United States
Coral Gables, Florida, United States
Deerfield Beach, Florida, United States
Plainfield, Illinois, United States
North Kansas City, Missouri, United States
Phoenix, Arizona, United States
San Luis Obispo, California, United States
Santa Maria, California, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Seattle, Washington, United States
Fort Worth, Texas, United States
Miami, Florida, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Pahrump, Nevada, United States
Stevens Point, Wisconsin, United States
Arroyo Grande, California, United States
Collegeville, Pennsylvania, United States
Exton, Pennsylvania, United States
Collierville, Tennessee, United States
Honolulu, Hawaii, United States
Ballwin, Missouri, United States
Washington, Missouri, United States
Plantation, Florida, United States
Fort Dodge, Iowa, United States
Redmond, Oregon, United States
Kingman, Arizona, United States
Dixon, Illinois, United States
Washington, Illinois, United States
Farmington, Missouri, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Santa Rosa, California, United States
Salt Lake City, Utah, United States
Celebration, Florida, United States
Covington, Louisiana, United States
'Ewa Beach, Hawaii, United States
Crown Point, Indiana, United States
Dyer, Indiana, United States
Hobart, Indiana, United States
Omaha, Nebraska, United States
Richardson, Texas, United States
Greenlawn, New York, United States
Pierre, South Dakota, United States
'Aiea, Hawaii, United States
Nampa, Idaho, United States
Alton, Illinois, United States
Springfield, Illinois, United States
Grand Island, Nebraska, United States
San Juan, , Puerto Rico
Sheboygan, Wisconsin, United States
Mineola, New York, United States
Kansas City, Missouri, United States
Des Moines, Iowa, United States
Dallas, Texas, United States
Rochester, New York, United States
Lebanon, New Hampshire, United States
Pontiac, Michigan, United States
Pittsburg, Kansas, United States
Ann Arbor, Michigan, United States
Brighton, Michigan, United States
Chelsea, Michigan, United States
Dayton, Ohio, United States
Danville, Illinois, United States
Greenville, Ohio, United States
Boone, Iowa, United States
Fort Dodge, Iowa, United States
Jefferson, Iowa, United States
Marshalltown, Iowa, United States
Ames, Iowa, United States
Canton, Michigan, United States
Minocqua, Wisconsin, United States
Ankeny, Iowa, United States
Sunset Hills, Missouri, United States
Des Moines, Iowa, United States
Clive, Iowa, United States
Hays, Kansas, United States
Jefferson City, Missouri, United States
Pontiac, Michigan, United States
Council Bluffs, Iowa, United States
Madison, Wisconsin, United States
Silverdale, Washington, United States
Saint Johnsbury, Vermont, United States
Dayton, Ohio, United States
Dayton, Ohio, United States
Johnson Creek, Wisconsin, United States
Royal Oak, Michigan, United States
Johnson Creek, Wisconsin, United States
Dearborn, Michigan, United States
Farmington Hills, Michigan, United States
Troy, Michigan, United States
Saginaw, Michigan, United States
Tawas City, Michigan, United States
Southfield, Michigan, United States
Novi, Michigan, United States
Madison, Wisconsin, United States
Detroit, Michigan, United States
Grosse Pointe Woods, Michigan, United States
Flint, Michigan, United States
Warren, Michigan, United States
East China Township, Michigan, United States
Macomb, Michigan, United States
Warren, Michigan, United States
Olathe, Kansas, United States
Grosse Pointe Woods, Michigan, United States
Mount Vernon, Illinois, United States
Ankeny, Iowa, United States
Clive, Iowa, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Denver, Colorado, United States
Waukee, Iowa, United States
Rolla, Missouri, United States
Pittsburg, Kansas, United States
Littleton, Colorado, United States
Parker, Colorado, United States
Cape Girardeau, Missouri, United States
Patients applied
Trial Officials
Kim A Reiss Binder
Principal Investigator
ECOG-ACRIN Cancer Research Group
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials